Szczeklik J, Szczeklik A, Nizankowski R
Br Heart J. 1980 Sep;44(3):254-8. doi: 10.1136/hrt.44.3.254.
Intra-arterial or intravenous infusion of prostacyclin at three dose levels (2, 5, and 10 ng/kg per min) in 10 subjects without evidence of coronary heart disease or cardiac failure, led to a distinct fall in peripheral and total pulmonary vascular resistances. This was accompanied by a drop in intra-arterial blood pressure, and the acceleration of heart rate. Stroke volume, cardiac output, mean right atrial pressure, and left ventricular end-diastolic pressure showed no significant changes. Except for sporadic headache no side effects occurred. Prostacyclin appears to act predominantly on resistance vessels. The haemodynamic effects produced by prostacyclin in man might be of clinical interest in the treatment of conditions associated with a significant rise in vascular resistance.
在10名无冠心病或心力衰竭证据的受试者中,以三种剂量水平(每分钟2、5和10纳克/千克)进行动脉内或静脉内输注前列环素,导致外周和总肺血管阻力明显下降。这伴随着动脉内血压下降和心率加快。每搏量、心输出量、平均右心房压和左心室舒张末期压力无显著变化。除偶发头痛外,未出现副作用。前列环素似乎主要作用于阻力血管。前列环素在人体产生的血流动力学效应可能对治疗与血管阻力显著升高相关的疾病具有临床意义。